176 related articles for article (PubMed ID: 28812814)
1. A Comparison of Iran and UK EQ-5D-3L Value Sets Based on Visual Analogue Scale.
Kiadaliri AA
Int J Health Policy Manag; 2017 May; 6(5):267-272. PubMed ID: 28812814
[TBL] [Abstract][Full Text] [Related]
2. Parallel Valuation: A Direct Comparison of EQ-5D-3L and EQ-5D-5L Societal Value Sets.
Law EH; Pickard AS; Xie F; Walton SM; Lee TA; Schwartz A
Med Decis Making; 2018 Nov; 38(8):968-982. PubMed ID: 30403577
[TBL] [Abstract][Full Text] [Related]
3. A head-to-head comparison of the EQ-5D-3L index scores derived from the two EQ-5D-3L value sets for China.
Zhang RY; Wang W; Zhou HJ; Xuan JW; Luo N; Wang P
Health Qual Life Outcomes; 2022 May; 20(1):80. PubMed ID: 35590333
[TBL] [Abstract][Full Text] [Related]
4. Valuation of Quality Weights for EuroQol 5-Dimensional Health States With the Time Trade-Off Method in the Capital of Iran.
Goudarzi R; Sari AA; Zeraati H; Rashidian A; Mohammad K; Amini S
Value Health Reg Issues; 2019 May; 18():170-175. PubMed ID: 31096140
[TBL] [Abstract][Full Text] [Related]
5. Does the choice of EQ-5D tariff matter? A comparison of the Swedish EQ-5D-3L index score with UK, US, Germany and Denmark among type 2 diabetes patients.
Kiadaliri AA; Eliasson B; Gerdtham UG
Health Qual Life Outcomes; 2015 Sep; 13():145. PubMed ID: 26374709
[TBL] [Abstract][Full Text] [Related]
6. Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries.
Bernert S; Fernández A; Haro JM; König HH; Alonso J; Vilagut G; Sevilla-Dedieu C; de Graaf R; Matschinger H; Heider D; Angermeyer MC;
Value Health; 2009; 12(5):750-8. PubMed ID: 19490564
[TBL] [Abstract][Full Text] [Related]
7. Comparing responsiveness of the EQ-5D-5L, EQ-5D-3L and EQ VAS in stroke patients.
Golicki D; Niewada M; Karlińska A; Buczek J; Kobayashi A; Janssen MF; Pickard AS
Qual Life Res; 2015 Jun; 24(6):1555-63. PubMed ID: 25425288
[TBL] [Abstract][Full Text] [Related]
8. Validity and reliability of the EQ-5D-3L (a generic preference-based instrument used for calculating quality-adjusted life -years) for patients with type 2 diabetes in Iran.
Zare F; Ameri H; Madadizadeh F; Aghaei MR
Diabetes Metab Syndr; 2021; 15(1):319-324. PubMed ID: 33486224
[TBL] [Abstract][Full Text] [Related]
9. A Comparison of EQ-5D-3L Index Scores Using Malaysian, Singaporean, Thai, and UK Value Sets in Indonesian Cervical Cancer Patients.
Endarti D; Riewpaiboon A; Thavorncharoensap M; Praditsitthikorn N; Hutubessy R; Kristina SA
Value Health Reg Issues; 2018 May; 15():50-55. PubMed ID: 29474178
[TBL] [Abstract][Full Text] [Related]
10. Health-related quality of life measured using the EQ-5D-3L: iranian population norms.
Mousavi A; Sari AA; Daastari F; Daroudi R
Expert Rev Pharmacoecon Outcomes Res; 2024 Jun; 24(5):643-651. PubMed ID: 38450671
[TBL] [Abstract][Full Text] [Related]
11. A comparison of four different approaches to measuring health utility in depressed patients.
Turner N; Campbell J; Peters TJ; Wiles N; Hollinghurst S
Health Qual Life Outcomes; 2013 May; 11():81. PubMed ID: 23659557
[TBL] [Abstract][Full Text] [Related]
12. Concordance among Swedish, German, Danish, and UK EQ-5D-3L Value Sets: Analyses of Patient-Reported Outcomes in the Swedish Hip Arthroplasty Register.
Teni FS; Rolfson O; Berg J; Leidl R; Burström K
J Clin Med; 2021 Sep; 10(18):. PubMed ID: 34575317
[No Abstract] [Full Text] [Related]
13. Population-Based Preference Weights for the EQ-5D Health States Using the Visual Analogue Scale (VAS) in Iran.
Goudarzi R; Zeraati H; Akbari Sari A; Rashidian A; Mohammad K
Iran Red Crescent Med J; 2016 Feb; 18(2):e21584. PubMed ID: 27186384
[TBL] [Abstract][Full Text] [Related]
14. Interim value set for the EQ-5D-5L in Iran using the Crosswalk method.
Ameri H; Safari H; Yousefi M; Bagheri Faradonbeh S; Goudarzi R; Soofi M
Med J Islam Repub Iran; 2020; 34():121. PubMed ID: 33437717
[No Abstract] [Full Text] [Related]
15. EQ-5D-5L measurement properties are superior to EQ-5D-3L across the continuum of health using US value sets.
Jiang R; Rand K; Kuharic M; Pickard AS
Health Qual Life Outcomes; 2022 Sep; 20(1):134. PubMed ID: 36085228
[TBL] [Abstract][Full Text] [Related]
16. A comparison of health utility scores calculated using United Kingdom and Canadian preference weights in persons with alzheimer's disease and their caregivers.
Fang M; Oremus M; Tarride JE; Raina P;
Health Qual Life Outcomes; 2016 Jul; 14(1):105. PubMed ID: 27431327
[TBL] [Abstract][Full Text] [Related]
17. Health-related quality of life in residents aged 18 years and older with and without disease: findings from the First Provincial Health Services Survey of Hunan, China.
Deng X; Dong P; Zhang L; Tian D; Zhang L; Zhang W; Li L; Deng J; Ning P; Hu G
BMJ Open; 2017 Sep; 7(9):e015880. PubMed ID: 28871016
[TBL] [Abstract][Full Text] [Related]
18. Comparing the UK EQ-5D-3L and English EQ-5D-5L Value Sets.
Mulhern B; Feng Y; Shah K; Janssen MF; Herdman M; van Hout B; Devlin N
Pharmacoeconomics; 2018 Jun; 36(6):699-713. PubMed ID: 29476363
[TBL] [Abstract][Full Text] [Related]
19. Head-to-Head Comparison of EQ-5D-3L and EQ-5D-5L Health Values.
Selivanova A; Buskens E; Krabbe PFM
Pharmacoeconomics; 2018 Jun; 36(6):715-725. PubMed ID: 29623559
[TBL] [Abstract][Full Text] [Related]
20. Similar responses to EQ-5D-3L by two elicitation methods: visual analogue scale and time trade-off.
Wang X; Zhuo L; Ma Y; Cai T; Must A; Xu L; Zhuo L
BMC Med Res Methodol; 2020 May; 20(1):118. PubMed ID: 32410582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
